A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This clinical research study is to learn about the safety of the NovoTTF-200M and Novo TTF-200A Systems, when used either alone or in combination with standard therapy, in patients with tumors that did not respond to treatment.
Epistemonikos ID: 6dd368af0daead09ca0daaa75dd7c383bed687f5
First added on: Apr 03, 2025